November2016

News Hour: A Japanese city on Tuesday reopened a busy street that collapsed into a giant sinkhole, with the efforts of workers who toiled around the clock for a week drawing praise on social media. The...

News Hour: UN chief Ban Ki-moon voiced hope on Tuesday that Donald Trump will “vary” his stance denying climate change as world leaders gathered in Morocco to keep a planetary rescue plan on track. A week...

News Hour: Emerging victorious from a campaign rife with vitriolic anti-immigrant rhetoric, President-elect Donald Trump has waffled on the specifics of his looming immigration policy. The Republican’s announcement on CBS’s “60 Minutes” that he would immediately...

News Hour: A strong and unified Europe is “good” for the United States and NATO is “absolutely vital” for US security and prosperity, US President Barack Obama said Tuesday as he launched his final European trip....

News Hour: It’s fair to say Donald Trump has weightier issues to deal with and it’s unlikely to trigger mass protests, but the US President-elect has secured another victory — over a flagpole. The 81-foot (25...

News Hour: Syrian government air strikes and barrel bomb attacks hit residential neighbourhoods of rebel-held east Aleppo on Tuesday for the first time in nearly a month, a monitor said. “Regime aircraft launched strikes and dropped...

News Hour: The US Food and Drug Administration (FDA) granted Priority Review to the PKC412 (midostaurin) new drug application (NDA) for the treatment of acute myeloid leukemia (AML) in newly-diagnosed adults with an FMS-like tyrosine kinase-3...

News Hour: New data showing Cosentyx® (secukinumab) delivers sustained improvements in the signs and symptoms of psoriatic arthritis (PsA) over three years – including patient-reported pain. These findings were presented at the 2016 Annual Meeting of...

News Hour: Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving...

News Hour: Tresiba® is a once-daily basal insulin that provides a duration of action beyond 42 hours. It is important for people with type 1 and type 2 diabetes to establish a routine for insulin treatment....